# Veradermics Shares Positive Hair Loss Study Results

> Veradermics reports strong Phase III trial results for male hair loss treatment.
- Title: Veradermics Shares Positive Hair Loss Study Results | Shortify
- Summary: Veradermics reports strong Phase III trial results for male hair loss treatment. Veradermics (MANE) achieved positive top line results from Phase III Study…
- Keywords: veradermics, mane, vdp hl01, phase iii study, male pattern hair loss, hair loss treatment, money, business, Shares, Positive, Hair, Loss
- Source: Seekingalpha — https://seekingalpha.com/article/4955225-veradermics-incorporated-mane-discusses-positive-top-line-results-from-phase-iii-study-304-of
- Author: SA Transcripts
- Published: 2026-10-19T20:13:59+00:00
- Read time: 1 min
- Topics: veradermics, mane, vdp hl01, phase iii study, male pattern hair loss, hair loss treatment, money, business
## Veradermics Shares Positive Hair Loss Study Results
Veradermics (MANE) reported positive top line results from Phase III Study 304 of VDPHL01 for male pattern hair loss.
## Company Leadership Present
Dominic Carrano, CFO & Treasurer, Reid Waldman, CEO & Director, and Mark Neumann, Chief Commercial & Strategy Officer joined the call.
## Clinical Perspective Coming
Dr. Michael Payette, Founder of Central Connecticut Dermatology, will provide clinical insights on patient impact.
## Key takeaway

Veradermics (MANE) achieved positive top line results from Phase III Study 304 of VDPHL01 for male pattern hair loss.